| Not Yet Recruiting | Baricitinib for Post-HSCT Persistent Thrombocytopenia NCT07535645 | Peking University People's Hospital | Phase 1 / Phase 2 |
| Recruiting | Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for All NCT07396480 | First Affiliated Hospital of Zhejiang University | Phase 3 |
| Not Yet Recruiting | Perianal MBL-CRE Colonization and Infection in Allogeneic Hematopoietic Stem Cell Transplant Patients NCT07324291 | Institute of Hematology & Blood Diseases Hospital, China | — |
| Not Yet Recruiting | Cardiovascular Complications in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. NCT07157670 | Assistance Publique - Hôpitaux de Paris | — |
| Not Yet Recruiting | Virtual Reality Intervention for Symptom Management in Stem Cell Transplantation NCT07145359 | Halic University | N/A |
| Recruiting | Immunoglobiulin-specific Prophylaxis of Citomegalovirus Infections in Immunocompromised Children Undergoing Al NCT07013370 | Antonello Di Paolo, M.D., Ph.D. | — |
| Active Not Recruiting | Maintenance Therapy With Selinexor and Azacitidine in TP53 Mutant AML/MDS After Transplantation NCT07094464 | Daihong Liu | Phase 1 |
| Not Yet Recruiting | Geriatric Assessment (GA) for Elderly Patients Undergoing Allo-HSCT NCT06946654 | Peking University People's Hospital | — |
| Recruiting | Nutrition OUtReach In Systems of Healthcare NCT06802406 | University of Kansas Medical Center | N/A |
| Enrolling By Invitation | Acupoint Application With Herbal Fumigation and Wash for Preventing Diarrhea-induced Perianal Infection in All NCT06912347 | Ruijin Hospital | N/A |
| Not Yet Recruiting | BuCy Vs. TBICy for Allo-HSCT in T-ALL Patients NCT06673459 | The First Affiliated Hospital of Soochow University | Phase 3 |
| Not Yet Recruiting | Abnormal Glucose Tolerance in Allogeneic Hematopoietic Stem Cell Transplantation NCT06704542 | Ruijin Hospital | — |
| Recruiting | Demethylating Agents Combined With Venetoclax for High-risk T-cell Lymphoblastic Lymphoma/Leukemia Post-Transp NCT06686108 | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Phase 2 |
| Recruiting | Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation NCT06028828 | University of California, Irvine | Phase 2 |
| Unknown | Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease (ABLE3.0/CTTC2201) NCT05692713 | University of British Columbia | — |
| Enrolling By Invitation | Reduced Intensity Conditioning Regimens for Acute Myeloid Leukemia and Myelodysplastic Syndrome NCT05674539 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 3 |
| Unknown | Clinical Study of TBF Regimen in Allo-HSCT in Patients With CNS Leukemia NCT05667402 | First Affiliated Hospital Xi'an Jiaotong University | N/A |
| Unknown | Hetrombopag for the Enhancement of Platelet Engraftment After Allogeneic Hematopoietic Stem Cell Transplantati NCT05727917 | Institute of Hematology & Blood Diseases Hospital, China | N/A |
| Unknown | The Gut Microbiome and Sorafenib Maintenance Therapy in FLT3-ITD Positive AML After Allo-HSCT NCT05596968 | Nanfang Hospital, Southern Medical University | — |
| Unknown | The Gut Microbiome in FLT3-ITD+ AML Undergoing Allo-HSCT With Or Without Sorafenib Maintenance After Allo-HSCT NCT05596981 | Nanfang Hospital, Southern Medical University | — |
| Unknown | The Gut Microbiome in FLT3- AL Undergoing Allo-HSCT With Or Without Sorafenib Maintenance NCT05601895 | Nanfang Hospital, Southern Medical University | — |
| Unknown | G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for High-risk MDS Undergoing Allo-HSCT NCT05453552 | Nanfang Hospital, Southern Medical University | Phase 2 / Phase 3 |
| Not Yet Recruiting | Impact of the Use of Allogeneic Hematopoietic Stem Cell Transplantation in Reunion Island Patients: Quality of NCT05327673 | Centre Hospitalier Universitaire de la Réunion | — |
| Unknown | G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for Secondary Acute Myeloid Leukemia Undergoing Allo-HSCT NCT05449899 | Nanfang Hospital, Southern Medical University | Phase 2 / Phase 3 |
| Unknown | Comparative Study of BFC and BuCy Conditioning Regimen for Allo-PBSCT in Acute B-cell ALL NCT05379569 | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Phase 4 |
| Unknown | Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Myeloid Leukemia and Myelodysplastic Syndr NCT05823714 | The First Affiliated Hospital of Soochow University | Phase 2 |
| Unknown | Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Lymphoblastic Leukemia Undergoing Allo-HSC NCT05809167 | The First Affiliated Hospital of Soochow University | Phase 2 |
| Completed | Sitagliptin for Prevention of aGVHD After Alternative Donor Transplation NCT05149365 | The First Affiliated Hospital of Soochow University | Phase 3 |
| Not Yet Recruiting | Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide for Re NCT05126186 | Assistance Publique - Hôpitaux de Paris | Phase 2 |
| Completed | A Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Efficacy of SER-155 in Adults Undergoing HSCT NCT04995653 | Seres Therapeutics, Inc. | Phase 1 |
| Unknown | Venetoclax Combining With Fludarabine and Melphalan as Conditioning Regimen for Allo-HSCT NCT05084027 | First Affiliated Hospital of Zhejiang University | Phase 2 |
| Unknown | Precision Dosing of Busulfan in Children Undergoing HSCT NCT04822532 | University Hospital, Geneva | N/A |
| Completed | Clinical Performance of SE-SPTM-PCR in Detecting Hcmv-miR-UL22A-5p After Hematopoietic Stem Cell Transplantati NCT07181330 | Ting YANG | — |
| Recruiting | Allogeneic Hematopoietic Stem Cell Transplantation Cohort Study NCT06708130 | Ruijin Hospital | — |
| Unknown | G-CSF+DAC+BUCY vs G-CSF+DAC+BF Conditioning Regimen for RAEB-1,REAB-2 and AML Secondary to MDS Undergoing Allo NCT04713956 | Nanfang Hospital, Southern Medical University | Phase 2 / Phase 3 |
| Completed | Chest Physical Therapy in Patients Waiting for Allogeneic Hematopoietic Stem Cell Transplantation" NCT05104684 | Cairo University | N/A |
| Unknown | CMV-TCR-T Cells for Refractory CMV Infection After HSCT NCT05089838 | Xiao-Jun Huang | Phase 1 |
| Unknown | Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study NCT04372524 | University of British Columbia | — |
| Unknown | Co-transplantation of MSC in the Setting of Allo-HSCT NCT04247945 | Fujian Medical University | Phase 2 / Phase 3 |
| Recruiting | Determination of Factors Involved in the Regulation of Immune Responses After Allogeneic Hematopoietic Stem Ce NCT03357172 | Central Hospital, Nancy, France | N/A |
| Unknown | Decitabine + BUCY vs BUCY Conditioning Regimen for TP53+ Myeloid Tumors Undergoing Allo-HSCT NCT04123392 | Nanfang Hospital, Southern Medical University | Phase 2 / Phase 3 |
| Unknown | Decitabine + BUCY vs BUCY Conditioning Regimen for Myeloid Tumors Undergoing Allo-HSCT NCT04098653 | Nanfang Hospital, Southern Medical University | Phase 2 / Phase 3 |
| Unknown | The Prospective Randomized Controlled Study of Eltrombopag on Hematopoietic Reconstruction After Allogeneic HS NCT03902041 | Shandong Provincial Hospital | — |
| Recruiting | Antigen Specific Adoptive T Cell Therapy for Adenovirus Infection After Hematopoietic Stem Cell Transplantatio NCT03378102 | Mari Dallas | EARLY_Phase 1 |
| Unknown | Effect of Prophylactic TKI Therapy Post-transplants on Ph+ ALL Undergoing Allo-HSCT With MRD Positive Pre-tran NCT03624530 | Nanfang Hospital, Southern Medical University | Phase 2 / Phase 3 |
| Unknown | Decitabine+BUCY vs BUCY Conditioning Regimen for MLL+ Acute Leukemia Undergoing Allo-HSCT NCT03596892 | Nanfang Hospital, Southern Medical University | Phase 2 / Phase 3 |
| Unknown | Dec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCT NCT03530085 | Nanfang Hospital, Southern Medical University | Phase 2 / Phase 3 |
| Unknown | Humor Therapy and Distress After Allogeneic Stem Cell Transplantation NCT03593161 | Universitätsklinikum Hamburg-Eppendorf | N/A |
| Unknown | Low Dose Decitabine + Modified BUCY Conditioning Regimen for High Risk Acute Myeloid Leukemia Undergoing Allo- NCT03256071 | The First Affiliated Hospital of Soochow University | Phase 2 / Phase 3 |
| Unknown | Changes in the Gut Microbiota of Patients Undergoing Allogeneic Stem Cell Transplantation (COLLECT) NCT03148197 | University of Cologne | — |
| Terminated | A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Dis NCT02993783 | Millennium Pharmaceuticals, Inc. | Phase 2 |
| Unknown | Chemotherapy and DLI for Prevention of Second Relapse in Patients With Relapsed Acute Leukemia After Allotrans NCT03297528 | Peking University People's Hospital | Phase 2 |
| Completed | Dose Finding Study of Vedolizumab for GvHD in Participants Undergoing Allogeneic HSCT NCT02728895 | Takeda | Phase 1 |
| Completed | G-CSF+Decitabine+BUCY vs BUCY Conditioning Regimen for RAEB-1, REAB-2 and AML Secondary to MDS Undergoing Allo NCT02744742 | Nanfang Hospital, Southern Medical University | Phase 2 / Phase 3 |
| Completed | BuCY vs TBICY Conditioning Regimen for Standard-risk ALL Undergoing Allo-HSCT NCT02670252 | Nanfang Hospital, Southern Medical University | Phase 3 |
| Terminated | A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Mali NCT02653196 | Montefiore Medical Center | EARLY_Phase 1 |
| Completed | MLN9708 for the Prophylaxis of Chronic Graft-versus-host Disease in Patient Undergoing Allogeneic Transplantat NCT02250300 | Mehdi Hamadani | Phase 1 / Phase 2 |
| Unknown | Non Randomized Comparative Study With Control NCT03294824 | Assistance Publique - Hôpitaux de Paris | — |
| Completed | Prospective Cohort for the Evaluation of Biomarkers Following HCT (BMT CTN 1202) NCT01879072 | Medical College of Wisconsin | — |
| Completed | Inspiratory Muscle Training in Allogeneic Hematopoietic Stem Cell Transplantation Recipients NCT02270346 | Gazi University | N/A |
| Unknown | Efficacy and Safety of rHuTPO on Platelet Engraftment After Allo-HSCT NCT01379391 | Nanfang Hospital, Southern Medical University | Phase 4 |
| Terminated | A Study to Accelerate Immune System Recovery Following Stem Cell Transplantation NCT00429039 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | Phase 2 |